ES8200861A1 - Procedimiento para la obtencion de acilpeptidos - Google Patents

Procedimiento para la obtencion de acilpeptidos

Info

Publication number
ES8200861A1
ES8200861A1 ES497696A ES497696A ES8200861A1 ES 8200861 A1 ES8200861 A1 ES 8200861A1 ES 497696 A ES497696 A ES 497696A ES 497696 A ES497696 A ES 497696A ES 8200861 A1 ES8200861 A1 ES 8200861A1
Authority
ES
Spain
Prior art keywords
amino acids
amino group
manufacture
well
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497696A
Other languages
English (en)
Other versions
ES497696A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8200861A1 publication Critical patent/ES8200861A1/es
Publication of ES497696A0 publication Critical patent/ES497696A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ACILPEPTIDOS DERIVADOS DE LA SOMATOSTATINA Y SUS ANALOGOS, ASI COMO DE LAS SALES NO TOXICAS Y COMPLEJOS FARMACOLOGICAMENTE UTILIZABLES DE LOS MISMOS. CONSISTE EN HACER REACCIONAR UN PEPTIDO CON UN ACIDO ALCANCARBOXILICO CON UN MAXIMO DE 18 ATOMOS DE CARBONO, O CON UN DERIVADO REACTIVO DE UN A-AMINOACIDO, EN EL CUAL LOS GRUPOS AMINO SE PRESENTAN EN FORMA PROTEGIDA Y LOS GRUPOS PROTECTORES SE DISOCIAN EN LA REACCION. TAMBIEN SE PUEDEN OBTENER ACILPEPTIDOS MEDIANTE CICLACION DE UN PEPTIDO LINEAL. LAS SALES DE ADICION, NO TOXICAS, SE OBTIENEN TRATANDO LOS ACILPEPTIDOS CON ACIDOS ORGANICOS O INORGANICOS. LOS ACILPEPTIDOS SE PUEDEN PRESENTAR EN FORMA DE COMPLEJOS, CON UNA ESTRUCTURA NO TOTALMENTE DEFINIDA, LOS CUALES SE FORMAN AL AGRAGAR DETERMINADAS SUSTANCIAS ORGANICAS O INORGANICAS A LOS PEPTIDOS. EL PROCESO OFRECE MULTIPLES VARIANTES. DE USO EN LA OBTENCION DE PREPARADOS CON FINES TERAPEUTICOS, ESPECIALMENTE PARA EL TRATAMIENTO DE PERTURBACIONES FUNCIONALESEN LAS CUALES LA SECRECION DE LA HORONA DE CRECIMIENTO O DE LA GLUCAGONA ES SUPERIOR A LA NORMAL.
ES497696A 1979-12-14 1980-12-12 Procedimiento para la obtencion de acilpeptidos Granted ES497696A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1109679 1979-12-14

Publications (2)

Publication Number Publication Date
ES8200861A1 true ES8200861A1 (es) 1981-11-16
ES497696A0 ES497696A0 (es) 1981-11-16

Family

ID=4370005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497696A Granted ES497696A0 (es) 1979-12-14 1980-12-12 Procedimiento para la obtencion de acilpeptidos

Country Status (18)

Country Link
US (1) US4369179A (es)
EP (1) EP0030920B1 (es)
JP (1) JPS5692850A (es)
KR (2) KR850000415B1 (es)
AT (1) ATE6251T1 (es)
AU (1) AU544256B2 (es)
CA (1) CA1161033A (es)
DD (1) DD154098A5 (es)
DE (1) DE3066654D1 (es)
DK (1) DK532180A (es)
ES (1) ES497696A0 (es)
FI (1) FI803849L (es)
GR (1) GR73621B (es)
IL (1) IL61696A0 (es)
NO (1) NO803757L (es)
NZ (1) NZ195817A (es)
PT (1) PT72191B (es)
ZA (1) ZA807796B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0083305B1 (de) * 1981-12-24 1985-07-10 Ciba-Geigy Ag Cyclische Octapeptide und pharmazeutische Präparate davon, sowie Verfahren zur Herstellung derselben und ihre Anwendung
FR2522655B1 (fr) * 1982-03-05 1987-03-06 Sanofi Sa Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
DE3379657D1 (en) * 1982-12-06 1989-05-24 Merck & Co Inc Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US5905140A (en) * 1996-07-11 1999-05-18 Novo Nordisk A/S, Novo Alle Selective acylation method
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
DE69822810T2 (de) * 1997-05-13 2005-02-03 Société de Conseils de Recherches et d'Applications Scientifiques S.A.S. Somatostatin und somatostatin agoniste zur behandlung der insulinsunempfindlichkeit und syndrome x
WO1998051330A1 (en) * 1997-05-13 1998-11-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Method and compositions for treating hyperlipidemia and other conditions
ATE245998T1 (de) * 1997-05-13 2003-08-15 Sod Conseils Rech Applic Somatostatin agoniste zur reduzierung von körpergewicht
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
US20030204063A1 (en) * 2000-08-02 2003-10-30 Denis Gravel Modified biological peptides with increased potency
ATE424414T1 (de) 2001-06-08 2009-03-15 Sod Conseils Rech Applic Chimere somatostatin-dopamin-analoga
US8709998B2 (en) 2003-04-22 2014-04-29 Ipsen Pharma S.A.S. Peptide vectors
EP2310029B1 (en) 2008-06-12 2019-04-03 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of cancer
CN102112145B (zh) 2008-06-12 2014-07-30 辛它可辛有限公司 神经内分泌病的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
ES2862125T3 (es) 2013-06-13 2021-10-07 Antisense Therapeutics Ltd Terapia combinada para acromegalia

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875207A (en) * 1967-01-25 1975-04-01 Ciba Geigy Corp Process for the temporary protection of amino groups in peptide syntheses
US3944590A (en) * 1967-01-25 1976-03-16 Ciba-Geigy Corporation Process for the temporary protection of amino groups in peptide syntheses
US3725380A (en) * 1969-04-05 1973-04-03 Hoechst Ag Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
CH517705A (de) * 1969-12-16 1972-01-15 Ciba Geigy Ag Verfahren zur Herstellung von Cystin-haltigen Peptiden
DE2202613C3 (de) * 1972-01-20 1974-06-20 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Verfahren zur Herstellung von Peptiden
CH577464A5 (es) * 1972-09-22 1976-07-15 Ciba Geigy Ag
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4113714A (en) * 1975-01-03 1978-09-12 American Home Products Corporation [Des-Ala1, Gly2 -desamino-Cys3 ]somatostatin
US4130554A (en) * 1975-04-08 1978-12-19 Merck & Co., Inc. Process for preparing somatostatin analog
US4000259A (en) * 1975-06-16 1976-12-28 American Home Products Corporation Cyclic dodecapeptide analogs of somatostatin and intermediates
US3988304A (en) * 1975-08-25 1976-10-26 American Home Products Corporation Cyclic dodecapeptide derivatives of somatostatin and intermediates thereof
CA1083143A (en) * 1976-01-02 1980-08-05 Nedumparambil A. Abraham Carba derivatives of somatostatin and process therefor
US4062816A (en) * 1976-03-11 1977-12-13 Eli Lilly And Company D-Ala5 -somatostatin and intermediates thereto
US4098782A (en) * 1977-03-14 1978-07-04 American Home Products Corporation (His5)-somatostatin and analogues thereof
US4118380A (en) * 1977-07-25 1978-10-03 Ayerst, Mckenna & Harrison Limited Decapeptide analogs of somatostatin
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs
US4202802A (en) * 1978-10-02 1980-05-13 Eli Lilly And Company Peptides related to somatostatin
US4191754A (en) * 1979-02-28 1980-03-04 Merck & Co., Inc. Bicyclic somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs

Also Published As

Publication number Publication date
CA1161033A (en) 1984-01-24
GR73621B (es) 1984-03-26
PT72191B (de) 1982-01-13
EP0030920A2 (de) 1981-06-24
KR850000415B1 (ko) 1985-03-26
ATE6251T1 (de) 1984-03-15
US4369179A (en) 1983-01-18
ES497696A0 (es) 1981-11-16
NO803757L (no) 1981-06-15
KR830004216A (ko) 1983-07-06
PT72191A (de) 1981-01-01
AU6534580A (en) 1981-06-18
DE3066654D1 (en) 1984-03-22
JPS5692850A (en) 1981-07-27
DK532180A (da) 1981-06-15
EP0030920B1 (de) 1984-02-15
ZA807796B (en) 1982-01-27
IL61696A0 (en) 1981-01-30
FI803849L (fi) 1981-06-15
AU544256B2 (en) 1985-05-23
KR850000414B1 (ko) 1985-03-26
EP0030920A3 (en) 1981-11-04
DD154098A5 (de) 1982-02-24
NZ195817A (en) 1984-07-06

Similar Documents

Publication Publication Date Title
ES8200861A1 (es) Procedimiento para la obtencion de acilpeptidos
ES8203385A1 (es) Procedimiento de obtencion de nuevos derivados de la vin- blastina
IL85020A (en) Pancreatic secretory trypsin inhibitor variants, their production, expression vectors and recombinant hosts therefor and pharmaceutical compositions containing them
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
IL72630A (en) Growth hormone-releasing peptides,their preparation and pharmaceutical preparations therefrom
ES8501364A1 (es) Un metodo para la preparacion de nuevos polipeptidos.
EP0330700A4 (en) Human prourokinase-like polypeptide.
GB1109086A (en) Polypeptides
ATE124955T1 (de) Substrat-peptide.
AU6393990A (en) Hiv related peptides
PT87239A (pt) Process for the preparation of peptides
Straus et al. Immunochemistry and end-group analyses of group A streptococcal M proteins
DE3867039D1 (de) Vincristin enthaltendes produkt.
GB1379937A (en) Preparation of lysine-containing peptides
ATE46173T1 (de) Pharmakologisch aktive peptide.
ES8204713A1 (es) Un procedimiento para aislar un polipeptido purificado
GB1353827A (en) Acthaction peptides and process for their manufacture
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES
ES2017811A6 (es) Procedimiento de obtencion de una nueva proteina especifica de la gestacion de mamiferos y de anticuerpos policlonales y monoclonales de lamisma, utilizables en el diagnostico precoz de gestacion o de mortalidad embrionaria de mamiferos.
GB1216141A (en) Peptides having acth-activity
JPS5551045A (en) Preparation of endorphin